Home

About Us

Advertisement

Contact Us

  • Facebook
  • X
  • Instagram
  • Pinterest
  • WhatsApp
  • RSS Feed
  • TikTok
edgeoptima, a blue and green hexagon logo

EdgeOptima

Maximize Your Edge.

  • Home
  • About
  • News
Search

Defensive Stocks Shine Amidst Global Gloom

Mahaesh Raajkumar Purty Avatar
Mahaesh Raajkumar Purty
April 8, 2025
Defensive Stocks Shine Amidst Global Gloom

As global economic clouds gather, investment strategists are turning towards a safety-first approach in the Indian markets. The recommendation is clear: focus on companies with strong domestic demand as tariffs and recession risks loom large internationally. Sectors like utilities, healthcare, telecom, financials, pharmaceuticals, consumer staples and quick commerce are being touted as relatively insulated from global economic shocks.

Domestic Demand is Key

Several Indian companies exemplify this domestic strength. Giants like NTPC and Power Grid Corp of India, primarily focused on the Indian market, are experiencing consistent growth driven by the nation’s ever-increasing electricity demand. Recent data from PharmaTrac indicates a healthy 7.5 percent sales growth in the Indian pharmaceutical market last month, showcasing the resilience of essential sectors. While an overall economic slowdown might moderate the pace of sales increase, fundamental needs such as healthcare, mobile services and insurance are unlikely to see drastic cuts in consumer spending. India Ratings and Research, for instance, projects a robust 13 percent growth in the general insurance market for FY26. Hospital revenues and telecom sector earnings, boosted by tariff revisions, are also projected to climb. As Nuvama Institutional Equities notes, sectors with stable demand, oligopolistic structures, favourable input costs, and reduced competitive pressure are the preferred picks.

Valuation Still a Concern

However, the optimism comes with a caveat. These defensive stocks are not bargain buys. Even after recent market corrections, many trade at valuations that are either premium to the broader market or on par with pre-COVID levels. The price-to-book value ratios of NTPC and Power Grid, for example, are considerably higher than in 2019. Healthcare leaders like Apollo Hospitals and Max Healthcare command forward price-to-earnings multiples of 50 and 60 times, respectively. This raises a crucial question: Are these stocks attractively priced for significant investment? The backdrop of softening corporate earnings and intensifying global and domestic economic headwinds suggests caution. Markets are bracing themselves for another quarter of lacklustre results.

FM Pushes India Growth Story

Interestingly, as markets navigate these uncertainties, Finance Minister Nirmala Sitharaman is actively promoting India’s growth narrative on the international stage. During her UK visit, she engaged with Prudential’s Chair, Shriti Vadera, highlighting the growth potential of India’s insurance sector, particularly in reinsurance and health insurance. She also showcased the opportunities within GIFT City, encouraging deeper engagement and investment. This proactive approach to attract foreign investment underscores India’s long-term growth ambitions, even as near-term global risks persist.

What should investors watch out for? If global trade tensions escalate and impact economic growth more severely than anticipated, FY26 earnings estimates may face downward revisions. This could trigger further stock price corrections and broader market valuation adjustments. Keeping a close eye on global economic signals and corporate earnings reports will be crucial in the coming months.

Image Courtesy: X (CNBC-TV18)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Featured Articles

  • RBI Eases Strict Project Finance Rule

    RBI Eases Strict Project Finance Rule

    June 20, 2025
  • India Firmly Rejects Trump Mediation Bid

    India Firmly Rejects Trump Mediation Bid

    May 14, 2025
  • Trump Targets Pharma Price War Looms

    Trump Targets Pharma Price War Looms

    May 13, 2025
  • Markets Surge Amid Global Thaw

    Markets Surge Amid Global Thaw

    May 12, 2025
  • India’s Resilience Shines Despite Border Jitters

    India’s Resilience Shines Despite Border Jitters

    May 9, 2025

Search

Author Details

Mahaesh Raajkumaar Purty

Mahaesh R. Purty

Mahaesh is a former engineer turned serial entrepreneur and finance expert with an MBA in Finance and over a decade of active trading experience. He delivers in-depth market research, insightful perspectives, and a unique take on finance. Beyond the markets, he explores spirituality and enjoys peaceful strolls in nature.

  • X
  • Instagram
  • TikTok
  • Facebook

Follow Us on

  • Facebook
  • X
  • Instagram
  • VK
  • Pinterest
  • Last.fm
  • TikTok
  • Telegram
  • WhatsApp
  • RSS Feed

Categories

  • Insights (228)
  • Market View (228)

Archives

  • June 2025 (1)
  • May 2025 (9)
  • April 2025 (20)
  • March 2025 (19)
  • February 2025 (19)
  • January 2025 (19)
  • December 2024 (21)
  • November 2024 (18)
  • October 2024 (22)
  • September 2024 (20)
  • August 2024 (21)
  • July 2024 (19)
  • June 2024 (18)
  • April 2024 (1)
  • January 2024 (1)

Tags

About Us

EDGEOPTIMA

Market news and expert insights, trading strategy benchmarks, product reviews, training and psychology resources to help you maximize your edge.

Latest Articles

  • RBI Eases Strict Project Finance Rule

    RBI Eases Strict Project Finance Rule

    June 20, 2025
  • India Firmly Rejects Trump Mediation Bid

    India Firmly Rejects Trump Mediation Bid

    May 14, 2025
  • Trump Targets Pharma Price War Looms

    Trump Targets Pharma Price War Looms

    May 13, 2025

Categories

  • Insights (228)
  • Market View (228)
  • Instagram
  • Facebook
  • LinkedIn
  • X
  • VK
  • TikTok

Copyright 2025 EdgeOptima.com

Scroll to Top